EPO Patents = 1

Forward Citations = 6

Loading Chart...

2 inventors (with patents filed for the assignee):

Tom Yao-Hsiang Wu (4 out of 24 patents)

Andrew T Miller (1 out of 2 patents)

4 patents: Sort by Forward Citations

1. 11173157 - Substituted pyrimidines containing acidic groups as TLR7 modulators (2021-11-16),

2. 10857153 - Pyrimidine compounds containing acidic groups (2020-12-08),

3. 10786502 - Substituted pyrimidines containing acidic groups as TLR7 modulators (2020-09-29),

4. 10287253 - Substituted pyrimidines containing acidic groups as TLR7 modulators (2019-05-14),

Apros Therapeutics, Inc. is a biopharmaceutical company focused on the development of novel therapeutics for the treatment of autoimmune and inflammatory diseases. Our mission is to improve the lives of patients through innovative research and drug development. With a strong pipeline of drug candidates, we are committed to bringing new treatment options to those in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

4 Patents

#974 in San Diego, CA

#13,684 in California

#59,078 in US

San Diego, CA, United States of America

Apros Therapeutics, Inc.

Forward Citations = 6

2 inventors:

Tom Yao-Hsiang Wu (4 out of 24 patents)

Andrew T Miller (1 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com